Literature DB >> 17030921

Intractable colitis associated with chronic granulomatous disease.

Yoshiaki Arimura, Akira Goto, Kentaro Yamashita, Takao Endo, Hideyuki Ikeda, Kaori Tanaka, Hiroyuki Tsutsumi, Yasuhisa Shinomura, Kohzoh Imai.   

Abstract

The case of a 20-year-old Japanese man, diagnosed as having autosomal recessive chronic granulomatous disease (CGD), who was being treated with corticosteroids for intractable unclassified colitis, is described. He died from multiple organ failure following disseminated intravascular coagulation secondary to disseminated varicella-zoster virus (VZV) infection. He was diagnosed as an index case of CGD when 2 years old, was inoculated against VZV at the age of 5 years and had had an unremarkable course for 19 years. He was admitted to hospital because of a third episode of recurrent bloody diarrhoea. Clinical remission for each episode was achieved by intravenous corticosteroid therapy. Unclassified colitis associated with CGD was diagnosed based on a colonic biopsy demonstrating characteristic macrophages with lipofuscin deposits. From a treatment viewpoint, idiopathic inflammatory bowel disease (IBD) should be differentiated from secondary IBD occurring in CGD, in which immunosuppressive drugs including corticosteroids, still the mainstay of IBD treatment, should be avoided.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030921     DOI: 10.1099/jmm.0.46722-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  A difficult case of Crohn's disease?

Authors:  Neville Azzopardi; Pierre Ellul; Thomas Attard; Jason Attard; James DeGaetano; Mario Vassallo; Tonio Piscopo
Journal:  BMJ Case Rep       Date:  2011-03-08

Review 2.  Role of NADPH oxidase in formation and function of multinucleated giant cells.

Authors:  Mark T Quinn; Igor A Schepetkin
Journal:  J Innate Immun       Date:  2009-07-07       Impact factor: 7.349

3.  High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease.

Authors:  Joyce E Yu; Suk See De Ravin; Gulbu Uzel; Carol Landers; Stephan Targan; Harry L Malech; Steven M Holland; Wenqing Cao; Noam Harpaz; Lloyd Mayer; Charlotte Cunningham-Rundles
Journal:  Clin Immunol       Date:  2010-10-16       Impact factor: 3.969

Review 4.  Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders.

Authors:  Ramona Goyal; Ariel C Bulua; Nikolay P Nikolov; Pamela L Schwartzberg; Richard M Siegel
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006

5.  The role of surgery in the management of patients with refractory chronic granulomatous disease colitis.

Authors:  Melissa M Alvarez-Downing; Natasha Kamal; Suzanne M Inchauste; Sajneet K Khangura; Harry L Malech; Steven M Holland; Marybeth S Hughes; Theo Heller; Richard M Sherry
Journal:  Dis Colon Rectum       Date:  2013-05       Impact factor: 4.585

6.  Colitis susceptibility in mice with reactive oxygen species deficiency is mediated by mucus barrier and immune defense defects.

Authors:  Gabriella Aviello; Ashish K Singh; Sharon O'Neill; Emer Conroy; William Gallagher; Giuseppe D'Agostino; Alan W Walker; Billy Bourke; Dimitri Scholz; Ulla G Knaus
Journal:  Mucosal Immunol       Date:  2019-09-25       Impact factor: 7.313

7.  High Levels of IL-18 and IFN-γ in Chronically Inflamed Tissue in Chronic Granulomatous Disease.

Authors:  Virginia Meda Spaccamela; Rocio G Valencia; Oleksandr Pastukhov; Andrea Duppenthaler; Matthias S Dettmer; Juliane Erb; Urs C Steiner; Sven Hillinger; Carsten Speckmann; Stephan Ehl; Janine Reichenbach; Ulrich Siler
Journal:  Front Immunol       Date:  2019-10-18       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.